Company announcement 13_23 Orphazyme appoints Jakob Bendtsen as new CEO
Kurs
-5,78%
Likviditet
0,02 MDKK
Kalender
| Est. tid* | ||
| 2025-09-16 | 16:50 | Kvartalsrapport 2025-Q2 |
| 2025-04-30 | N/A | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2025-04-29 | N/A | Årsstämma |
| 2025-03-31 | - | Bokslutskommuniké 2024 |
| 2024-08-20 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2024-04-11 | - | Årsstämma |
| 2024-04-04 | - | Bokslutskommuniké 2023 |
| 2023-12-06 | - | Split STRAP 1000:1 |
| 2023-11-02 | - | Extra Bolagsstämma 2023 |
| 2023-09-12 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-22 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2023-05-17 | - | Årsstämma |
| 2023-04-25 | - | Bokslutskommuniké 2022 |
| 2022-09-26 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-29 | - | Årsstämma |
| 2022-06-28 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2022-06-07 | - | Bokslutskommuniké 2021 |
| 2022-02-15 | - | Extra Bolagsstämma 2022 |
| 2021-08-31 | - | Kvartalsrapport 2021-Q2 |
| 2021-03-26 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2021-03-25 | - | Årsstämma |
| 2021-03-02 | - | Bokslutskommuniké 2020 |
| 2020-09-21 | - | Extra Bolagsstämma 2020 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-03-27 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2020-03-26 | - | Årsstämma |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2020-01-25 | - | Extra Bolagsstämma 2019 |
| 2019-08-28 | - | Kvartalsrapport 2019-Q2 |
| 2019-03-28 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2019-03-27 | - | Årsstämma |
| 2019-03-01 | - | Bokslutskommuniké 2018 |
| 2018-08-28 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-13 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2018-04-12 | - | Årsstämma |
| 2018-03-15 | - | Bokslutskommuniké 2017 |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Small Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Bioteknik |
As mentioned in announcement 11/2023 the Company and CEO/CFO Anders Fink Vadsholt entered into a severance agreement at May 30th 2023, where Mr. Vadsholt would step down as CEO/CFO of the Company no later than October 1st 2023, or when a replacement had been found.
The company has today signed an CEO agreement with Jakob Bendtsen who will be the new CEO of the company as from the October 1st 2023. Jakob Bendtsen will continue in his role as board member.
Chairman Michael Hove states: I’m happy to welcome Jakob Bendtsen in the company as our new CEO. Jakob has the perfect profile and competencies to lead the company forward in the search for a new activity for the company.
Furthermore, on behalf of the board I would like to acknowledge Anders Fink Vadsholt for his dedicated work during the past 1.5 year as CEO/CFO to hand over the activity and preparing the company for a new activity. I wish Anders all the best in the future”.
Herlev, September 20nd, 2023
The Board of Directors
For additional information, please contact
Michael Hove, Chairman of the board +45 28 12 66 09